Generics Market Research Reports

Sort By :

Title	Published	Price
CADILA HEALTHCARE LTD, Upgrade to Outperform - Best Poised beyond Patent Cliff – Complex Generics launches on the horizon *By MP Advisors* We upgrade Cadila Healthcare to Outperform and increase price target from `815 to `1050, as we build into our model forecasts for its high margin / low competition opportunities (Mesalamine franchise, Trasnsdermal patches and Urokinase). We see Cadil	April 2013	$ 140
AstraZeneca – On the verge of a breakdown - Respiratory portfolio (Symbicort and Pulmicort) threatened by Generics *By MP Advisors* The respiratory portfolio of AZN which so far has withstood generics attack, is now giving away. Yesterday’s court ruling invalidating pulmicort respule patent and Teva filing a MAA in Europe for a generic equivalent of Symbicort has really shaken	April 2013	$ 90
International Directory of Generics Companies 2013 *By Asia Pacific InfoServ Pty Ltd* The most comprehensive and accurate Directory of companies and executives in the generics industry InternationallyAPI research into generics companies and corporationsGlobal	February 2013	$ 275
Glenmark Generics Inc., USA - Strategic SWOT Analysis Review *By GlobalData* This comprehensive SWOT profile of Glenmark Generics Inc., USA provides you with an in-depth strategic analysis of the company''s businesses and operations. The profile will give you a clear and an unbiased view of the company''s key strengths and weak	June 2012	$ 250
Glenmark Generics Limited - Strategic SWOT Analysis Review *By GlobalData* This comprehensive SWOT profile of Glenmark Generics Limited provides you with an in-depth strategic analysis of the company''s businesses and operations. The profile will give you a clear and an unbiased view of the company''s key strengths and weakne	June 2012	$ 250
International Directory of Generics Companies 2012 *By Asia Pacific InfoServ Pty Ltd* This powerful directory is your connection to the key decision-makers in the Generics pharmaceutical industry worldwide. The International Directory of Generics Companies 2012 is the most comprehensive and accurate Directory of companies and execu...	February 2012	$ 275
Generics: Global Industry Guide *By MarketLine* is an essential resource for top-level data and analysis covering the Generics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and prof<	September 2011	$ 1495
International Pharmaceutical Generics (IPG) Ltd-Therapeutic Competitors Report *By Life Science Analytics* Report includes a business , tabular representation of the number and percentage of products in each therapeutic indication, all company products listed w...	March 2011	$ 350
Niche Generics Limited-Therapeutic Competitors Report *By Life Science Analytics* Report includes a business , tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage ...	March 2011	$ 350
Arrow Generics Ltd-Therapeutic Competitors Report *By Life Science Analytics* Report includes a business , tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of d...	March 2011	$ 350
Mylan (formerly Generics (UK) Limited)-Therapeutic Competitors Report *By Life Science Analytics* Report includes a business , tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indic...	March 2011	$ 350
Niche Generics Limited-Detailed Product Pipeline *By Life Science Analytics* provides up to date insight into company’s business description, product information, pipeline details including both information and detailed individual product records.S...	March 2011	$ 750
International Pharmaceutical Generics (IPG) Ltd-Detailed Product Pipeline *By Life Science Analytics* provides up to date insight into company’s business description, product information, pipeline details including both information and detailed individual prod...	March 2011	$ 750
Zydus Cadila Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Sandoz Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Sanofi-Aventis Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Sawai Pharmaceuticals Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Simcere Pharmaceuticals Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Stada Arzneimittel Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Sun Pharmaceuticals Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Teva Pharmaceutical Industries Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Wockhardt Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry...	January 2011	$ 340
Krka Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Lannett Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into t...	January 2011	$ 340
Lupin Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into t...	January 2011	$ 340
Mylan Laboratories Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry playe...	January 2011	$ 340
Par Pharmaceutical Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry...	January 2011	$ 340
Perrigo Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry...	January 2011	$ 340
Ranbaxy Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry...	January 2011	$ 340
ratiopharm Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Aspen Pharmacare Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Cipla Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Dr Reddy's Laboratories Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Egis Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Gedeon Richter Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into t...	January 2011	$ 340
Hospira Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Impax Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Actavis Generics Company Intelligence Report *By Espicom Limited* Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight ...	January 2011	$ 340
Apotex Generics Company Intelligence Report *By Espicom Limited* Apotex is active in around 115 countries, and has subsidiaries, joint ventures or licensing agreements in Asia, Europe and Latin America. Products are sold under the Apotex brand,...	January 2011	$ 340
Generics in Canada *By Datamonitor* Datamonitor's industry profile is an essential resource for top-level data and analysis covering the Generics industry. It includes data on market size and segmentation, plus textu...	September 2010	$ 250

Home › Mining & Utilities › Generics

Generics Market Research Reports

Related Reports on